| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2018 | Adjuvant radiotherapy after curative surgery for oral cavity squamous cell carcinoma and treatment effect of timing and duration on outcome—A Taiwan Cancer Registry national database analysis | Cheng Y.-J.; Tsai M.-H.; CHUN-JU CHIANG ; Tsai S.-T.; Liu T.-W.; PEI-JEN LOU ; Liao C.-T.; Lin J.-C.; Chang J.T.-C.; Tsai M.-H.; Chu P.-Y.; Leu Y.-S.; Tsai K.-Y.; Terng S.-D.; Chien C.-Y.; Yang M.-H.; Hao S.-P.; Wang C.-C.; Tsai M.-H.; Chen H.H.W.; Kuo C.; Wu Y.-H. | Cancer Medicine | 22 | 19 | |
| 1989 | Adult non-Hodgkin's lymphoma in Taiwan area: A clinicopathologic study of 123 cases based on working formulation classification | ANN-LII CHENG ; YAO-CHANG CHEN ; Su I.-J.; Wang C.-H.; Hsieh H.-C.; Chen C.-L.; HONG-SHIEE LAI ; Liu T.-W.; HWEI-FANG TIEN ; MING-CHING SHEN ; Liu C.-H. | Journal of the Formosan Medical Association | 12 | 0 | |
| 2022 | Association of Smoking With Patient Characteristics and Outcomes in Small Cell Lung Carcinoma, 2011-2018 | Tseng J.-S.; CHUN-JU CHIANG ; Chen K.-C.; Zheng Z.-R.; Yang T.-Y.; WEN-CHUNG LEE ; Hsu K.-H.; Huang Y.-H.; Liu T.-W.; Hsia J.-Y.; Chang G.-C. | JAMA network open | 9 | 13 | |
| 2018 | Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan | Hsieh M.-H.; Yeh M.-L.; TUNG-HUNG SU ; Liu T.-W.; Huang C.-F.; Huang C.-I.; Wang S.-C.; Huang J.-F.; Dai C.-Y.; JIA-HORNG KAO ; Chuang W.-L.; PEI-JER CHEN ; CHUN-JEN LIU ; Yu M.-L. | Journal of the Formosan Medical Association | 5 | 4 | |
| 2016 | Characteristics of young lung cancer: Analysis of Taiwan's nationwide lung cancer registry focusing on epidermal growth factor receptor mutation and smoking status | Hsu C.-H.; Tseng C.-H.; CHUN-JU CHIANG ; Hsu K.-H.; Tseng J.-S.; Chen K.-C.; Wang C.-L.; Chen C.-Y.; Yen S.-H.; Chiu C.-H.; Huang M.-S.; CHONG-JEN YU ; Tsai Y.-H.; JIN-SHING CHEN ; Tsai C.-M.; Chou T.-Y.; Lin K.-C.; Tsai M.-H.; WEN-CHUNG LEE ; Ku H.-Y.; Liu T.-W.; Yang T.-Y.; Chang G.-C. | Oncotarget | 36 | 30 | |
| 2014 | Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study | CHIUN HSU ; Tsou H.-H.; Lin S.-J.; Wang M.-C.; MING YAO ; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.; Chang C.-S.; HWEI-FANG TIEN ; Liu T.-W.; PEI-JER CHEN ; ANN-LII CHENG | Hepatology | 217 | 206 | |
| 2022 | Clinical Outcomes of Taiwanese Patients with Resected Oral Cavity Squamous Cell Carcinoma Who Underwent Reconstruction with Free Versus Local Flaps | Liao C.-T.; Wen Y.-W.; Lee S.-R.; Ng S.-H.; Liu T.-W.; Tsai S.-T.; Tsai M.-H.; Lin J.-C.; Chien C.-Y.; PEI-JEN LOU ; Wang C.-P.; Chu P.-Y.; Leu Y.-S.; Tsai K.-Y.; Terng S.-D.; Chen T.-M.; Wang C.-H.; Chen W.-C.; Lee L.-Y.; Lin C.-Y.; Wang H.-M.; Fang T.-J.; Huang S.-F.; Kang C.-J.; Chang K.-P.; Yen T.-C.; Yang L.-Y.; Lin C.-H.; for the Taiwan Oral Cavity Cancer Advisory Group | Annals of Surgical Oncology | 2 | 2 | |
| 2015 | A decade of changes in preferences for life-sustaining treatments among terminally ill patients with cancer | Tang S.T.; Liu T.-W.; Wen F.-H.; CHIUN HSU ; Chang Y.-H.; Chang C.-S.; Sung Y.-C.; Hsieh C.-I.; Chang S.-Y.; Liu L.N.; Chiang M.-C. | JNCCN Journal of the National Comprehensive Cancer Network | 10 | 10 | |
| 2010 | Determinants of patient-family caregiver congruence on preferred place of death in Taiwan | Tang S.T.; CHERYL CHIA-HUI CHEN ; Tang W.-R.; Liu T.-W. | Journal of Pain and Symptom Management | 17 | 16 | |
| 2012 | Development and Validation of an Instrument for the Measurement of Health-Related Quality of Life Based on View of Traditional Chinese Medicine Perspective | Chang H.-H.; WEI-CHU CHIE ; Chin Y.-H.; Hsu C.-P.; Liu T.-W.; Whang-Peng J. | Journal of Traditional and Complementary Medicine | 1 | 0 | |
| 1989 | Direct comparisons of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades - Should peripheral T-cell lymphoma be considered separately? | ANN-LII CHENG ; YAO-CHANG CHEN ; Wang C.-H.; Su I.-J.; Hsieh H.-C.; Chang J.-Y.; Hwang W.-S.; Su W.-C.; Liu T.-W.; HWEI-FANG TIEN ; Tsai W.; MING-CHING SHEN ; Liu C.-H. | Journal of Clinical Oncology | 70 | 65 | |
| 2004 | Effect of Calcium Channel Blockers on Vertebral Bone Marrow Perfusion of the Lumbar Spine | TIFFANY TING-FANG SHIH ; Chang C.-J.; WEN-YIH TSENG ; Hsiao J.-K.; Shen L.-C.; Liu T.-W.; PAN-CHYR YANG | Radiology | 15 | 16 | |
| 2021 | Long-term survival effect of the interval between postoperative chemotherapy and radiotherapy in patients with completely resected pathological n2 non-small-cell lung cancer | Lin S.-M.; Ku H.-Y.; CHE-YU HSU ; Wang C.-L.; Chang G.-C.; Chang C.-S.; Liu T.-W. | Cancers | 2 | 1 | |
| 2020 | A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue | Tsai H.-J.; Tai J.J.; Chen L.-T.; MING-SHIANG WU ; KUN-HUEI YEH ; CHUNG-WU LIN ; Wang T.-E.; HSIU-PO WANG ; Yu F.-J.; JYH-MING LIOU ; Hsiao C.-F.; TSU-YAO CHENG ; Yeh H.-J.; Ko C.-W.; Chen M.-J.; Lo G.-H.; Hsu P.-I.; Chang C.-S.; Hwang W.-S.; Chuang S.-S.; Lee H.-W.; CHIA-TUNG SHUN ; Chiu C.-F.; Wang W.-M.; Hsieh C.-Y.; Liu T.-W.; Lin J.-T.; SUNG-HSIN KUO ; ANN-LII CHENG | Haematologica | 4 | 4 | |
| 2005 | Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma | Chan A.T.C.; Hsu M.-M.; Goh B.C.; Hui E.P.; Liu T.-W.; Millward M.J.; RUEY-LONG HONG ; Whang-Peng J.; Ma B.B.Y.; To K.F.; Mueser M.; Amellal N.; Lin X.; Chang A.Y. | Journal of Clinical Oncology | 256 | 217 | |
| 2020 | An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas | Chen M.-H.; Chou W.-C.; Hsiao C.-F.; Jiang S.S.; Tsai H.-J.; Liu Y.-C.; CHIUN HSU ; Shan Y.-S.; Hung Y.-P.; Hsich C.-H.; Chiu C.-H.; Liu T.-C.; Cho S.-F.; Liu T.-W.; Chao Y. | Oncologist | 5 | 4 | |
| 2006 | Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma | Shiah H.-S.; Chao Y.; Chen L.-T.; Yao T.-J.; Huang J.-D.; Chang J.-Y.; PEI-JER CHEN ; Chuang T.-R.; Chin Y.-H.; Whang-Peng J.; Liu T.-W. | Cancer Chemotherapy and Pharmacology | 11 | 12 | |
| 2006 | Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer | Ch'ang H.-J.; Wang C.-C.; ANN-LII CHENG ; CHIUN HSU ; YEN-SHEN LU ; MING-CHU CHANG ; Lin J.-T.; HSIU-PO WANG ; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T. | Journal of Gastroenterology and Hepatology (Australia) | 8 | 8 | |
| 2006 | Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer | Shiah H.-S.; ANN-LII CHENG ; CHIUN HSU ; CHIH-HUNG HSU ; Liu T.-W.; Chang J.-Y.; Jan C.-M.; Chao Y.; Yu W.-L.; Chuang T.-R.; Whang-Peng J.; Chen L.-T. | Journal of Gastroenterology and Hepatology (Australia) | 6 | 5 | |
| 2006 | Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma | Wang C.-C.; Chang J.-Y.; Liu T.-W.; Lin C.-Y.; Yu Y.-C.; RUEY-LONG HONG | Head and Neck | 50 | 46 |
